AMGROS I/S has floated a tender for Contract notice: Pharmaceutical products. The project location is Denmark and the tender is closing on 20 Sep 2018. The tender notice number is 357871-2018, while the TOT Ref Number is 25899125. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Denmark

Summary : Contract notice: Pharmaceutical products

Deadline : 20 Sep 2018

Other Information

Notice Type : Tender

TOT Ref.No.: 25899125

Document Ref. No. : 357871-2018

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AMGROS I/S
Office Name: Amgros I/S
Address: Dampfærgevej 22
Town: Copenhagen
Postal Code: 2100
Contact Point: Flemming Sonne

Phone: +45 88713000
Fax: +45 88713008
Denmark
Email :udbud@amgros.dk
URL :http://www.amgros.dk

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33600000
CPV Description: Pharmaceutical products.

Amgros 2018-1.267.a.

Amgros is a partnership with the 5 regions as stakeholders. In order to provide stakeholders' hospital pharmacies with drugs and the resale of individual stakeholders to the Faroe Islands and Greenland, Amgros I / S wishes to enter into framework agreements for the medicinal products listed in Section II.2.4. The framework agreements are non-exclusive. Amgros I / S reseller lowerthe funds to the hospital pharmacies for Amgros I / S' purchase price with an addendum. Framework agreements are entered without specification, and hospital pharmacies in the regions are not obliged to apply Amgros' framework agreements.

Main Site: Place of delivery is the address of Amgros at the address (hospital pharmacy or affiliated locations).

The tender number includes the following medicines:

Offer No: 1,

ATC Code: L01XC13,

Generic name: Pertuzumab,

Dispensing form: Concentration, concentration,

Strength: 420 mg,

Unit value: 20 mg,

Amount in units: 58 527.

The above drugs are offered independently of the drugs under the remaining tendering numbers.

Each tender number is considered a separate sub-agreement. A supplier will thus be able to bid on one or more or all of the tender numbers and the award is made sepfor each individual tender number. Reference is made to the terms of reference, including the submission of tenders under the individual tender numbers.

The term "quantity in units" indicates the estimated consumption of the drugs under the tender number.

It is noted that this amount is based on historical consumption and that the suppliers It is common ground that the actual purchase under a framework agreement may differadmitted from there. Reference is made to the terms of the tender terms. 3.6 and the Framework Agreement Item. 2. The medicinal product must have a marketing authorization valid for Denmark by 20.9.2018 at. 12:00. Furthermore, at the time of the expiry of the deadline and during the duration of the framework agreement, the supplier shall be authorized to manufacture, import or wholesale pharmaceuticals within the EU / E0S.

LeAmendments wishing to submit tenders must use the standard form for the Single European Procurement Document (ESPD) to issue a declaration regarding the mandatory grounds for exclusion in - 135-136 of the Procurement Act (Act No. 1564 of 15 December 2015 with amendments). Further information on the completion and application of ESPD in the procurement process can be found in the instructions provided by Amgros for this and in KoCompetition and Consumer Agency's "Guide to the Single European Public Procurement Document". The winning supplier (s) that Amgros intends to award the framework agreement must, before the award, have made documentation available to Amgros in so far as the mandatory grounds for exclusion, cf. - 152 - 153 of the Procurement Act. Amgros can not exclude a supplier that includest of one or more of the mandatory grounds for exclusion in section 135-136 of the Public Procurement Act, the safeguard supplier may provide sufficient evidence that the supplier is, in any case, palpable, cf. section 138 of the Procurement Act. Amgros reserves the right to carry out such a self-cleaning process, safely if the mat is relevant.

No information required. II.2.3 notes that a-overview of delivery points is available on Amgros' Delivery and Procurement Portal, https://levportal.amgros.dk. The overview is updated on the basis of the changes.

In relation to item no. II.2.4 notes that Amgros has considered whether the tender group can be further subdivided. Amgros has realized that this is not the case in the light of considerations of economies of scale that will notre realizable by a further breakdown as well as costs and patient safety considerations related to the following contract and drug handling. II.1.5 and point II.2.6 noted that the estimated value in section. II.1.5 is the total estimated value of all tender numbers (lots) in the duration of the framework agreement incl. possibility of extension, cf. II.2.7. In section. II.2.6 is the estimated value of each tender number incl. possibility of extension given, cf. II.2.7.

It should also be noted that the estimated value is based on historical consumption and that the actual purchase may therefore deviate significantly therefrom, cf. II.2.4, Item No. of the Terms and Conditions. 3.6 and the Framework Agreement Item. 2. The questionnaire for the tender documents must be stated in the tender system, cf. uThe provisions of the terms of reference for this purpose.

Access to tender requires that the company be established as a user of Amgros' procurement system. There may be some processing days associated with user creation, and it is therefore inconceivable for any bidders to do so in good time. Reference is made to information relating to the procurement system, including the user guide. IV.2.4 notes that some parts of the offer may also be in English. Reference is made to the terms of the tender terms. 4.1.

In relation to point VI.2 noted that electronic invoicing is required
Internet address (URL): http://www.amgros.dk

Documents

 Tender Notice